Collegeville, PA, United States of America

Yujie Liu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: 23Andme, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yujie Liu. Retrieved from https://idiyas.com/inventor/yujie-liu-urhd3cdq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yujie Liu: Innovator in Cancer Treatment

Introduction

Yujie Liu is a prominent inventor based in Collegeville, PA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic antibodies.

Latest Patents

Yujie Liu holds a patent for Anti-ULBP6 antibodies. This patent relates to a ULBP6 binding protein that inhibits the interaction between ULBP6 and NKG2D. The methods described in her patent offer potential treatments for cancer using this ULBP6 binding protein.

Career Highlights

Yujie Liu is currently employed at 23andMe, Inc., where she continues to advance her research in biotechnology and therapeutic applications. Her work has garnered attention for its potential impact on cancer therapies.

Collaborations

Yujie Liu collaborates with notable colleagues, including Joel Benjamin and Shashank Bharill. These partnerships enhance her research efforts and contribute to the development of innovative solutions in the medical field.

Conclusion

Yujie Liu's contributions to cancer treatment through her patent and work at 23andMe, Inc. highlight her role as a leading inventor in the biotechnology sector. Her innovative approaches continue to pave the way for advancements in cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…